Price Alert

Apyx Medical Corporation (APYX)

NASDAQ: APYX · Real-Time Price · USD

2.17

0.05 (2.36%)

At close: Aug 15, 2025, 3:47 PM

Apyx Medical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	29.3M	31.01M	31.74M	28.01M	32.68M	37.28M	43.65M	22.13M	18.48M	16.25M	10.19M	14.83M	20.06M	26.23M	30.87M	30.9M	34.67M	39.54M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.72M	1.77M	1.66M	1.78M	1.81M	1.89M	1.73M	1.85M	1.91M	1.24M	1.22M	1.25M	1.27M	1.31M	1.11M	1.05M	1.03M	860K
Receivables	11.25M	11.64M	15.48M	13.04M	12.71M	12.49M	14.05M	13.24M	20.14M	18.14M	18.25M	16.66M	18.02M	20.12M	21.16M	19.97M	18.02M	16.45M
Inventory	8.19M	7.68M	7.56M	9M	9.32M	9.79M	9.92M	11.29M	11.17M	10.95M	11.8M	12.04M	9.68M	7.02M	6.78M	6.04M	5.27M	4.46M
Other Current Assets	1.17M	1.51M	1.66M	2.11M	1.96M	2.36M	2.73M	3.49M	3.1M	7.35M	2.74M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	49.91M	51.85M	56.44M	52.16M	56.67M	61.93M	70.36M	50.15M	52.88M	52.68M	42.97M	46.31M	50.52M	54.81M	60.74M	59.88M	61.58M	63.04M
Property-Plant & Equipment	6.55M	6.54M	6.74M	6.78M	6.91M	6.89M	7.15M	7.44M	7.64M	2.86M	7.59M	7.71M	7.68M	6.87M	6.87M	6.84M	6.98M	7.19M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.27M	8.31M	8.4M	8.56M	8.72M	8.79M	8.88M	9.3M	9.54M	4.1M	8.8M	8.96M	8.95M	8.19M	7.98M	7.89M	8.02M	8.05M
Total Assets	58.19M	60.16M	64.84M	60.72M	65.39M	70.71M	79.24M	59.45M	62.43M	56.78M	51.77M	55.27M	59.47M	63M	68.72M	67.77M	69.6M	71.1M
Account Payables	2.89M	2.31M	2.62M	1.91M	2.35M	2.1M	2.71M	2.05M	2.66M	1.91M	2.67M	2.07M	2.59M	2.56M	2.63M	3.04M	2.8M	2.28M
Deferred Revenue	1.48M	430K	693K	499K	778K	515K	488K	712K	442K	1.05M	853K	1.15M	821K	759K	8.42M	6.51M	5.84M	5.38M
Short-Term Debt	398K	n/a	n/a	n/a	n/a	376K	367K	330K	8.89M	8.78M	n/a	282K	195K	205K	n/a	343K	352K	357K
Other Current Liabilities	4.3M	n/a	5.08M	n/a	4.56M	4.74M	4.94M	3.38M	3.78M	4.02M	n/a	10.52M	4.65M	4.51M	4.94M	3.6M	3.47M	3.81M
Total Current Liabilities	10.57M	9.51M	10.72M	9.55M	10.64M	10.56M	12.74M	10.29M	19.03M	18.53M	11.85M	11.19M	11.35M	11.6M	13.21M	11.71M	10.74M	9.73M
Long-Term Debt	4.32M	34.13M	33.89M	33.85M	33.63M	33.41M	33.19M	9.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	35.85M	270K	259K	201K	192K	194K	198K	181K	185K	185K	181K	133K	142K	151K	166K	146K	145K	141K
Total Long-Term Liabilities	40.17M	40.01M	39.79M	39.97M	39.83M	39.7M	39.58M	15.57M	6.67M	2.04M	2.13M	1.86M	1.96M	1.55M	1.51M	1.4M	1.17M	1.2M
Total Liabilities	50.73M	49.52M	50.51M	49.52M	50.47M	50.25M	52.32M	25.86M	25.7M	20.57M	13.98M	13.05M	13.31M	13.15M	14.71M	13.11M	11.91M	10.93M
Total Debt	4.71M	38.92M	38.76M	38.85M	38.7M	38.63M	38.5M	14.39M	14.41M	9.51M	796K	814K	802K	218K	305K	395K	491K	558K
Common Stock	38K	38K	38K	35K	35K	35K	35K	35K	35K	35K	35K	35K	34K	34K	34K	34K	34K	34K
Retained Earnings	-85.84M	-82.06M	-77.91M	-73.28M	-68.58M	-62.02M	-54.45M	-44.84M	-40.21M	-39.22M	-35.73M	-29.69M	-23.92M	-18.5M	-12.55M	-10.55M	-6.33M	-2.28M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	0.00	n/a	n/a	-0.00	0.00	-0.00	0.00	-0.00	-0.00
Shareholders Equity	7.25M	10.51M	14.21M	11.04M	14.75M	20.25M	26.7M	33.35M	36.6M	36.05M	37.58M	41.99M	45.91M	49.56M	53.7M	54.35M	57.36M	60.03M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a